Cystitis News and Research

Latest Cystitis News and Research

First patient dosed in second Phase 2 study with LiRIS for treatment of Interstitial Cystitis

First patient dosed in second Phase 2 study with LiRIS for treatment of Interstitial Cystitis

New therapeutic approach for bladder pain syndrome

New therapeutic approach for bladder pain syndrome

Canine lymphoma treatment adds up to cystitis

Canine lymphoma treatment adds up to cystitis

Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Risk factors for urinary tract disease also common in idiopathic cystitis, in cats

Risk factors for urinary tract disease also common in idiopathic cystitis, in cats

One-week ciprofloxacin effective for pyelonephritis

One-week ciprofloxacin effective for pyelonephritis

Vulvodynia confers risk for other chronic pain syndromes

Vulvodynia confers risk for other chronic pain syndromes

The Patient Recruiting Agency announces enrollment for research study of women with IC/BPS

The Patient Recruiting Agency announces enrollment for research study of women with IC/BPS

Women with vulvodynia more likely to also have other chronic pain conditions

Women with vulvodynia more likely to also have other chronic pain conditions

Mylan introduces Mesna Injection

Mylan introduces Mesna Injection

Study aims to develop noninvasive method to analyze interstitial cystitis

Study aims to develop noninvasive method to analyze interstitial cystitis

ICN Food List for interstitial cystitis/bladder pain syndrome patients

ICN Food List for interstitial cystitis/bladder pain syndrome patients

Cefpodoxime not effective in treating uncomplicated cystitis in women

Cefpodoxime not effective in treating uncomplicated cystitis in women

Breakthroughs in hematopoietic cell transplantation to be presented at 53rd ASH meeting

Breakthroughs in hematopoietic cell transplantation to be presented at 53rd ASH meeting

Laurantis Pharma's Lymfactin rebuilds lymphatic vessels in pre-clinical animal models

Laurantis Pharma's Lymfactin rebuilds lymphatic vessels in pre-clinical animal models

Amgen's Prolia receives FDA approval for new indications to treat cancer patients

Amgen's Prolia receives FDA approval for new indications to treat cancer patients

Amgen to present data from several Prolia studies at ASBMR 2011 meeting

Amgen to present data from several Prolia studies at ASBMR 2011 meeting

Researchers find new molecule that controls pain sensitivity from UVB irradiation

Researchers find new molecule that controls pain sensitivity from UVB irradiation

UCLA's new center to explore links between brain, digestive system in chronic disorders

UCLA's new center to explore links between brain, digestive system in chronic disorders

New approach for treatment of infections of urinary tract

New approach for treatment of infections of urinary tract